PEGylated Chitosan Biodegradable Nanoparticles Delivery of Salvia officinalis and Melissa officinalis for Enhanced Brain Targeting


Cite item

Full Text

Abstract

Background:Alzheimer's disease (AD) is a progressive neurodegenerative condition characterized by the gradual decline of cognitive abilities, primarily caused by impairments in the cholinergic system. AD is diagnosed based on the presence of specific pathological features, in-cluding senile plaques, neurofibrillary tangles, and the loss of neurons and synapses. Despite on-going efforts, the etiology of AD remains unclear, and there is a significant lack of effective treatments to meet the medical needs of affected individuals. The complex nature of AD, involv-ing multiple factors, presents challenges in the development of potential therapies. Numerous ob-stacles hinder the achievement of optimal pharmacological concentration of promising molecules for AD treatment. These obstacles include the presence of the blood-brain barrier (BBB), which restricts the entry of therapeutic agents into the brain, as well as issues related to poor bioavaila-bility and unfavorable pharmacokinetic profiles. Unfortunately, many therapeutically promising compounds have failed to overcome these hurdles and demonstrate efficacy in treating AD.

Methods:The PEGylated chitosan nanoconjugate was developed and evaluated for delivery of anti-Alzheimer natural extract of Salvia officinalis and Melissa officinalis to the brain. The nano-conjugates (S-PCN and M-PCN) were developed by ionic gelation technique.

Result:The nanoconjugates (S-PCN and M-PCN) were evaluated for various optical and in-vitro parameters. MTT assay on UCSD229i-SAD1-1 human astrocytoma cells indicated IC50 values of 0.42, 0.49, 0.67, and 0.75 µM for S-PCN, M-PCN formulations, and free Salvia officinalis and Melissa officinalis extracts, respectively. The In vitro assessments using cell lines have confirmed the improved uptake and distribution of nanoconjugates compared to free extracts. These findings were validated through confocal microscopy and apoptosis assays, revealing a substantial in-crease in the accumulation of nanoconjugates within the brain. The targeting potential OF M- PCN over S-PCN was found to be 2-fold significant.

Conclusion:Based on the findings, it can be inferred that biodegradable PEGylated chitosan nanoconjugates hold promise as effective nano-targeting agents for delivering anti-Alzheimer drugs to the brain. The incorporation of PEGylated chitosan nanoparticles in this approach demonstrates enhanced delivery capabilities, ultimately leading to improved therapeutic out-comes.

About the authors

Sanjana Datta

SVN Institute of Pharmaceutical Sciences, Swami Vivekanad University, Pharmacy, Swami Vivekananda University

Email: info@benthamscience.net

Asmita Gajbhiye

Pharmaceutical Sciences, Dr. Hari Singh Gour Central University

Email: info@benthamscience.net

Shailendra Patil

Pharmacy, SVN Institute of Pharmaceutical Sciences, Swami Vivekanad University

Author for correspondence.
Email: info@benthamscience.net

References

  1. Moradkhani H, Sargsyan E, Bibak H, et al. Melissa officinalis L., a valuable medicine plant: A review. J Med Plants Res 2010; 4: 2753-9.
  2. Atanassova M, Georgieva S, Ivancheva K. Total phenolic and total flavonoid contents, antioxidant capacity and biological contaminants in medicinal herbs. J Univ Chem Tech Met 2011; 46: 81-8.
  3. Peng CC, Hsieh CL, Wang HE, Chung JY, Chen KC, Peng RY. Ferulic acid is nephrodamaging while gallic acid is renal protective in long term treatment of chronic kidney disease. Clin Nutr 2012; 31(3): 405-14. doi: 10.1016/j.clnu.2011.11.003 PMID: 22154988
  4. Anwar J, Spanevello RM, Thomé G, et al. Effects of caffeic acid on behavioral parameters and on the activity of acetylcholinesterase in different tissues from adult rats. Pharmacol Biochem Behav 2012; 103(2): 386-94. doi: 10.1016/j.pbb.2012.09.006 PMID: 22982740
  5. Sun L, Guo Y, Fu C, Li J, Li Z. Simultaneous separation and purification of total polyphenols, chlorogenic acid and phlorizin from thinned young apples. Food Chem 2013; 136(2): 1022-9. doi: 10.1016/j.foodchem.2012.09.036 PMID: 23122158
  6. Zarei A, Changizi-Ashtiyani S, Taheri S, Hosseini N. A brief overview of the effects of Melissa officinalis L. extract on the function of various body organs. Zahedan J Res Med Sci 2015; 17(7): 29-34. doi: 10.17795/zjrms1007
  7. Gülçin S. a study on the in vitro antioxidant activity of juniper (Juniperus communis L.) seeds extracts. Anal Lett 2006; 39: 47-65. doi: 10.1080/00032710500423385
  8. Ramanauskiene K, Stelmakiene A. Assessment of lemon balm (Melissa officinalis l.) hydrogels: Quality and bioactivity in skin cells. Evid Based Complement Alternat Med 2015; 2015: 635975.
  9. Zhou JR, Fujiwara E, Nakamura Y, Nakasima MN, Yokomizo K. Effects of Lemon Balm essential oil application on atopic dermatitis-like immune alterations in mice. Int J Phytomed 2015; 7: 46-54.
  10. Ippoushi K, Yamaguchi Y, Itou H, Azuma K, Higashio H. Evaluation of inhibitory effects of vegetables and herbs on hyaluronidase and identification of rosmarinic acid as a hyaluronidase inhibitor in lemon balm (Melissa officinalis L.). Food Sci Technol Res 2000; 6(1): 74-7. doi: 10.3136/fstr.6.74
  11. Kim J, Lee H, Lim J, Oh J, Shin S, Yoon M. The angiogenesis inhibitor ALS-L1023 from lemon-balm leaves attenuates high-fat diet-induced nonalcoholic fatty liver disease through regulating the visceral adipose-tissue function. Int J Mol Sci 2017; 18(4): 846. doi: 10.3390/ijms18040846 PMID: 28420164
  12. Yoon M, Kim MY. The anti-angiogenic herbal composition Ob-X from Morus alba, Melissa officinalis, and Artemisia capillaris regulates obesity in genetically obese ob/ob mice. Pharm Biol 2011; 49(6): 614-9. doi: 10.3109/13880209.2010.539617 PMID: 21554004
  13. Zomer HD, Trentin AG. Skin wound healing in humans and mice: Challenges in translational research. J Dermatol Sci 2018; 90(1): 3-12. doi: 10.1016/j.jdermsci.2017.12.009 PMID: 29289417
  14. Mohd Ariffin NH, Hasham R. Assessment of non-invasive techniques and herbal-based products on dermatological physiology and intercellular lipid properties. Heliyon 2020; 6(5): e03955. doi: 10.1016/j.heliyon.2020.e03955
  15. Soica C, Oprean C, Borcan F, et al. The synergistic biologic activity of oleanolic and ursolic acids in complex with hydroxypropyl-y-cyclodextrin. Molecules 2014; 19: 4924-40. doi: 10.3390/molecules19044924 PMID: 24747649
  16. Coricovac DE, Moacă EA, Pinzaru I, et al. Biocompatible colloidal suspensions based on magnetic iron oxide nanoparticles: Synthesis, characterization and toxicological profile. Front Pharmacol 2017; 8: 154. doi: 10.3389/fphar.2017.00154 PMID: 28400730
  17. Ribatti D. The chick embryo chorioallantoic membrane in the study of tumor angiogenesis. Rom J Morphol Embryol 2008; 49(2): 131-5. PMID: 18516317
  18. Avram S, Danciu C, Pavel IZ, et al. Polyphenols, antioxidant activity and anti-angiogenic potential of red and white grapes. Rev Chim 2016; 67: 382-5.
  19. Danciu C, Coricovac DE. Evaluation of skin physiological parameters in SKH1 mice experimental model after exposure to aggressive factors like UVB using non-invasive methods. Rev Chim 2014; 65: 1195-9.
  20. Mahboubi M. Melissa officinalis and rosmarinic acid in management of memory functions and Alzheimer disease. Asian Pac J Trop Biomed 2019; 9: 47-52.
  21. Lee J, Jung E, Koh J, Kim YS, Park D. Effect of rosmarinic acid on atopic dermatitis. J Dermatol 2008; 35(12): 768-71. doi: 10.1111/j.1346-8138.2008.00565.x PMID: 19239556
  22. Hamaguci T, Ono K, Murase A, Yamada M. Phenolic compounds prevent Alzheimer’s pathology through different effects on the amyloid-beta aggregation pathway. Am J Pathol 2009; 175: 2557-65.
  23. Ghayour N, Behnam RM, Afsharian M, Tehranipour M. The protective effects of Melissa officinalis leaves usage on learning disorder induced by lead acetate administration during pre and postnatal periods in rats. J Arak Univ Med Sci 2010; 13: 97-104.
  24. Martins EN, Pessano NTC, Leal L, et al. Protective effect of Melissa officinalis aqueous extract against Mn-induced oxidative stress in chronically exposed mice. Brain Res Bull 2012; 87(1): 74-9. doi: 10.1016/j.brainresbull.2011.10.003 PMID: 22020131
  25. Shakeri A, Sahebkar A, Javadi B. Melissa officinalis L. - A review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol 2016; 188: 204-28. doi: 10.1016/j.jep.2016.05.010 PMID: 27167460
  26. Lin SH, Chou ML, Chen WC, et al. A medicinal herb, Melissa officinalis L. ameliorates depressive-like behavior of rats in the forced swimming test via regulating the serotonergic neurotransmitter. J Ethnopharmacol 2015; 175: 266-72. doi: 10.1016/j.jep.2015.09.018 PMID: 26408043
  27. Kato-Noguchi H. Assessment of allelopathic potential of shoot powder of lemon balm. Sci Hortic 2003; 97(3-4): 419-23. doi: 10.1016/S0304-4238(02)00159-0
  28. Haybar H, Javid AZ, Haghighizadeh MH, Valizadeh E, Mohaghegh SM, Mohammadzadeh A. The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina. Clin Nutr ESPEN 2018; 26: 47-52. doi: 10.1016/j.clnesp.2018.04.015 PMID: 29908682
  29. Aubert P, Guinobert I, Blondeau C, et al. Basal and spasmolytic effects of a hydroethanolic leaf extract of Melissa officinalis L. on intestinal motility: An ex vivo study. J Med Food 2019; 22(7): 653-62. doi: 10.1089/jmf.2018.0154 PMID: 30990736
  30. Skotti E, Kountouri S, Bouchagier P, Tsitsigiannis DI, Polissiou M, Tarantilis PA. FTIR spectroscopic evaluation of changes in the cellular biochemical composition of the phytopathogenic fungus Alternaria alternata induced by extracts of some Greek medicinal and aromatic plants. Spectrochim Acta A Mol Biomol Spectrosc 2014; 127: 463-72. doi: 10.1016/j.saa.2014.02.113 PMID: 24657421
  31. Ersoy S, Orhan I, Turan NN, Şahan G, Ark M, Tosun F. Endothelium-dependent induction of vasorelaxation by Melissa officinalis L. ssp. officinalis in rat isolated thoracic aorta. Phytomedicine 2008; 15(12): 1087-92. doi: 10.1016/j.phymed.2008.05.007 PMID: 18606529
  32. Barros L, Dueñas M, Dias MI, Sousa MJ, Santos-Buelga C, Ferreira ICFR. Phenolic profiles of cultivated, in vitro cultured and commercial samples of Melissa officinalis L. infusions. Food Chem 2013; 136(1): 1-8. doi: 10.1016/j.foodchem.2012.07.107 PMID: 23017385
  33. Binello A, Cravotto G, Boffa L, et al. Efficient and selective green extraction of polyphenols from lemon balm. C R Chim 2017; 20(9-10): 921-6. doi: 10.1016/j.crci.2017.06.003
  34. Skotti EP, Sotiropoulou NSD, Lappa IK, Kaiafa M, Tsitsigiannis DI, Tarantilis PA. Screening of lemon balm extracts for anti-aflatoxigenic, antioxidant and other biological activities. Preprints 2019; 2019070005.
  35. Sahu P, Kashaw SK, Sau S, et al. pH triggered and charge attracted nanogel for simultaneous evaluation of penetration and toxicity against skin cancer: In-vitro and ex-vivo study. Int J Biol Macromol 2019; 128: 740-51. doi: 10.1016/j.ijbiomac.2019.01.147 PMID: 30699336
  36. Arjariya S, Jain R, Sharma N. Development and toxicological evolution of pegylated chitosan nanoparticle for the simultaneous delivery of silymarin and dehydroemetine for the enhance hepatic targeting. J Pharm Negat Results 2022; 13(8): 4732-9.
  37. Sahin A, Yoyen-Ermis D, Caban-Toktas S, et al. Evaluation of brain-targeted chitosan nanoparticles through blood–brain barrier cerebral microvessel endothelial cells. J Microencapsul 2017; 34(7): 659-66. doi: 10.1080/02652048.2017.1375039 PMID: 28862080
  38. Wilson B, Mohamed Alobaid BN, Geetha KM, Jenita JL. Chitosan nanoparticles to enhance nasal absorption and brain targeting of sitagliptin to treat Alzheimer’s disease. J Drug Deliv Sci Technol 2021; 61: 102176. doi: 10.1016/j.jddst.2020.102176
  39. Caprifico AE, Foot PJ, Polycarpou E, Calabrese G. Overcoming the blood-brain barrier: Functionalised chitosan nanocarriers. Pharmaceutics 2020; 12(11): 1013.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers